A study of nearly two million U.S. children documented a 250%+ rise in anxiety-related visits over a decade, yet the observational design—lacking randomization and relying on claims data—limits causal claims and may reflect heightened awareness or diagnostic shifts rather than pure incidence growth. Sample size is robust, but potential conflicts from insurer-funded analyses warrant scrutiny. Synthesizing this with CDC's 2023 MMWR report (n=over 100k households, observational) showing 37% of high-schoolers with persistent sadness, and a 2022 JAMA Pediatrics cohort study (n=1.2M, pre/post-pandemic comparison) linking remote learning isolation to doubled internalizing disorders, the pattern points to sustained neurodevelopmental impacts from disrupted social scaffolding. Original coverage missed how economic pressures on families amplify cortisol pathways in children, creating intergenerational costs estimated at $1T+ annually by 2030 per WHO modeling. Peer-reviewed evidence underscores need for school-based interventions over reactive care.